BlackRock’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.39M | Buy |
621,689
+591,419
| +1,954% | +$3.22M | ﹤0.01% | 3849 |
|
|
2025
Q1 | $167K | Hold |
30,270
| – | – | ﹤0.01% | 4592 |
|
|
2024
Q4 | $152K | Hold |
30,270
| – | – | ﹤0.01% | 4623 |
|
|
2024
Q3 | $140K | Hold |
30,270
| – | – | ﹤0.01% | 4557 |
|
|
2024
Q2 | $167K | Sell |
30,270
-11,900
| -28% | -$65.7K | ﹤0.01% | 4534 |
|
|
2024
Q1 | $411K | Buy |
42,170
+40,900
| +3,220% | +$399K | ﹤0.01% | 4363 |
|
|
2023
Q4 | $10.7K | Buy |
+1,270
| New | +$10.7K | ﹤0.01% | 5062 |
|
|
2022
Q4 | – | Sell |
-2,728,633
| Closed | -$27.1M | – | 5730 |
|
|
2022
Q3 | $27.1M | Sell |
2,728,633
-318
| -0% | -$3.16K | ﹤0.01% | 2828 |
|
|
2022
Q2 | $26.9M | Hold |
2,728,951
| – | – | ﹤0.01% | 2866 |
|
|
2022
Q1 | $26.7M | Hold |
2,728,951
| – | – | ﹤0.01% | 2924 |
|
|
2021
Q4 | $27M | Sell |
2,728,951
-21,049
| -0.8% | -$208K | ﹤0.01% | 3037 |
|
|
2021
Q3 | $27.3M | Hold |
2,750,000
| – | – | ﹤0.01% | 3030 |
|
|
2021
Q2 | $26.7M | Hold |
2,750,000
| – | – | ﹤0.01% | 3073 |
|
|
2021
Q1 | $26.6M | Buy |
+2,750,000
| New | +$26.6M | ﹤0.01% | 2981 |
|